CN1076445A - 取代的苯基喹唑啉衍生物 - Google Patents

取代的苯基喹唑啉衍生物 Download PDF

Info

Publication number
CN1076445A
CN1076445A CN93102010A CN93102010A CN1076445A CN 1076445 A CN1076445 A CN 1076445A CN 93102010 A CN93102010 A CN 93102010A CN 93102010 A CN93102010 A CN 93102010A CN 1076445 A CN1076445 A CN 1076445A
Authority
CN
China
Prior art keywords
compound
hydrogen
carbon atom
chemical formula
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN93102010A
Other languages
English (en)
Chinese (zh)
Inventor
P·L·安德逊
W·J·豪力汉
P·K·卡帕
A·库切罗维
P·G·马特纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of CN1076445A publication Critical patent/CN1076445A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CN93102010A 1992-03-03 1993-03-02 取代的苯基喹唑啉衍生物 Pending CN1076445A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84512392A 1992-03-03 1992-03-03
US845,123 1992-03-03

Publications (1)

Publication Number Publication Date
CN1076445A true CN1076445A (zh) 1993-09-22

Family

ID=25294463

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93102010A Pending CN1076445A (zh) 1992-03-03 1993-03-02 取代的苯基喹唑啉衍生物

Country Status (14)

Country Link
EP (1) EP0564397A1 (no)
JP (1) JPH0649076A (no)
KR (1) KR930019642A (no)
CN (1) CN1076445A (no)
AU (1) AU3387593A (no)
CA (1) CA2090635A1 (no)
CZ (1) CZ30293A3 (no)
FI (1) FI930922A (no)
HU (1) HUT63629A (no)
IL (1) IL104892A0 (no)
NO (1) NO930739L (no)
NZ (1) NZ247032A (no)
TW (1) TW227563B (no)
ZA (1) ZA931516B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104119231A (zh) * 2013-04-27 2014-10-29 重庆华邦制药有限公司 二苯甲胺类化合物的制备方法及中间体

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1655289A1 (en) * 2004-11-04 2006-05-10 Embl Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives
CN103562198B (zh) * 2011-06-10 2016-08-24 奇斯药制品公司 具有毒蕈碱受体拮抗剂和β2肾上腺素能受体激动剂活性的化合物
WO2015120059A1 (en) * 2014-02-04 2015-08-13 Yates Charles Ryan Inhibitors of paxillin function and related compositions and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242863A (en) * 1968-05-10 1971-08-18 Pharmacia As 2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
DE3734909A1 (de) * 1987-10-15 1989-04-27 Boehringer Ingelheim Kg Verwendung von oxochinazolinderivaten bei der behandlung der hyperlipidaemie

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104119231A (zh) * 2013-04-27 2014-10-29 重庆华邦制药有限公司 二苯甲胺类化合物的制备方法及中间体

Also Published As

Publication number Publication date
TW227563B (no) 1994-08-01
NO930739D0 (no) 1993-03-01
ZA931516B (en) 1994-09-03
CZ30293A3 (en) 1993-12-15
HUT63629A (en) 1993-09-28
NZ247032A (en) 1994-11-25
KR930019642A (ko) 1993-10-18
HU9300556D0 (en) 1993-05-28
EP0564397A1 (en) 1993-10-06
IL104892A0 (en) 1993-07-08
AU3387593A (en) 1993-09-09
FI930922A0 (fi) 1993-03-02
CA2090635A1 (en) 1993-09-04
FI930922A (fi) 1993-09-04
NO930739L (no) 1993-09-06
JPH0649076A (ja) 1994-02-22

Similar Documents

Publication Publication Date Title
CN1072218C (zh) 1－(巯甲基)环丙烷乙酸的制备工艺
CN1173953C (zh) 制备-4-羧基氨基-2-取代的-1,2,3,4-四氢喹啉的方法
CN101039917A (zh) 制备替米沙坦的方法
CN1402711A (zh) 作为cetp抑制剂的4－羧基氨基－2－乙基－1,2,3,4－四氢喹啉结晶
CN1914202A (zh) 1－(2s,3s)－2－二苯甲基－n－(5－叔丁基－2－甲氧基苄基)奎宁环－3－胺的制备方法
CN100343227C (zh) 坦洛新的拆分方法
CN1038639A (zh) 旋光的萘并硫氮杂类的制备方法
CN1048014C (zh) 取代的吡咯类化合物及其制法、药物组合物和用途
CN1211974A (zh) 喹啉－2－(1h)－酮
CN1308307C (zh) 假多晶型的卡维地洛
CN87105804A (zh) 卤化-3-卤代-2-羟基丙基三甲基铵的制备方法
CN1009826B (zh) 制备喹啉基化合物的方法
CN1076445A (zh) 取代的苯基喹唑啉衍生物
CN1876646A (zh) 马来酸桂哌齐特改进的制备方法
CN1030389C (zh) 制备1,5-苯并硫氮杂䓬衍生物的方法
CN1221743A (zh) 取代杂环的苯并环烯烃及其作为具有镇痛作用的物质的用途
CN1051545C (zh) 5－(芳氧基甲基)噁唑啉,其制备方法和含它们的药物组合物
CN1139588C (zh) 新的氟化咪唑啉苯并二噁烷,其制备及其治疗用途
CN1296372C (zh) 制备吲哚－2,3－二酮－3－肟衍生物的对映异构体的方法
CN1148594A (zh) 哌啶基甲基噁唑烷酮
CN1742002A (zh) 新的哌嗪衍生物和它们作为合成中间体的应用
CN1278249A (zh) 用作药物的联苯基衍生物
CN1724525A (zh) γ－丁内酯衍生物及其制备方法
CN1033795A (zh) 制备光学活性棉酚的方法
CN1247525C (zh) N－(取代苯基)丙氨酸及其酯的制备方法及其旋光构型体的消旋方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication